Promore: LL-37 HEAL study cleared in Poland
Research Note
2018-08-22
10:13
The phase IIb study with LL-37 in patients with chronic venous leg ulcers is now cleared in both Sweden and Poland. The first patients could be included in the coming months.
MS
Mathias Spinnars
Disclosures and disclaimers